Cynata Therapeutics Limited
CYYNF
$0.118
$0.01615.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.84M | -6.13M | -6.39M | -7.72M | -9.12M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 182.70K | 183.90K | 184.10K | 184.70K | 186.30K |
| Total Other Non-Cash Items | 837.30K | 498.50K | 153.60K | 811.00K | 1.49M |
| Change in Net Operating Assets | -478.30K | -478.30K | -478.30K | -467.40K | -462.30K |
| Cash from Operations | -5.30M | -5.92M | -6.53M | -7.19M | -7.91M |
| Capital Expenditure | -33.10K | -16.80K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -33.10K | -16.80K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.00M | 4.00M | -- | 3.52M | 7.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -510.60K | -255.30K | -- | -158.90K | -317.80K |
| Cash from Financing | 4.95M | 2.51M | -- | 2.25M | 4.54M |
| Foreign Exchange rate Adjustments | -44.30K | -23.20K | -300.00 | -35.40K | -70.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -423.10K | -3.45M | -6.53M | -4.98M | -3.43M |